Government of Afghanistan Report issue

Government Phase 3

Organization Overview

First Clinical Trial
2007
NCT00682578
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Ministry of public Health Afghanistan | Research Dept. Ministry of Public Health (MoPH) Afghanistan

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Malaria (Phase 3)

Malaria, Falciparum (Phase 3)

Malaria, Vivax (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 6